Literature DB >> 21897298

Management of post septic hip dislocations when the capital femoral epiphysis is present.

Ashok N Johari1, Arjun A Dhawale, Ratna A Johari.   

Abstract

Delayed or missed diagnosis of septic arthritis of hip in children results in various sequelae. The group of post septic hip dislocations when the capital femoral epiphysis (CFE) is present has not been described in the commonly used classifications. This is a retrospective series of 21 hips in 18 children. The presence of the CFE was confirmed radiologically or at the time of intervention. The mean follow-up after intervention was 6.3 years. Interventions for dislocations included closed reduction ± adductor tenotomy, open reduction ± supplementary femoral procedures, and acetabular procedures. Results were evaluated clinically with Ponseti hip scoring and radiologically with the modified Severin grading. Closed reduction was successful in seven of 20 hips (35%) and open reduction in 13 of 14 hips. At follow-up, good clinical result was seen in nine of 18 cases (50%). The mean neck shaft angle was 129° in all hips and 124° after femoral varus osteotomy. There was one redislocation and three subluxations. The modified Severin classification was class 2 in five hips (good), class 3 in 12 hips (fair), class 4 in three hips (poor), and class 6 in one hip (failure). Septic hip dislocation with CFE present is a distinct entity. MRI is helpful for planning treatment. A significant number of patients need open reduction with other procedures. Femoral varus osteotomy may contribute to coxa vara. In the short term, intervention results in a stable, functional, and mobile hip.

Entities:  

Mesh:

Year:  2011        PMID: 21897298     DOI: 10.1097/BPB.0b013e32834af5f0

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  1 in total

1.  Pathological dislocation of the hip due to coxotuberculosis in children: a 29-case report.

Authors:  Xin Jiang; Yuan Li; Lijun Liu; MingXin Peng; XueYang Tang; DaoXi Wang; XiaoDong Yang
Journal:  J Orthop Surg Res       Date:  2014-03-10       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.